Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Insulin combined with acarbose or metformin for glycemic control in adults with type 1 diabetes
ChiCTR1800019426Phase 4Not yet recruiting
- Sponsor
- The Third Affiliated Hospital of Sun Yat-sen University
- Start
- Nov 2018
- Modality
- Small Molecules, Microbiome-Derived Products → Microbiome Therapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised trial of human insulin, acarbose and metformin in diabetes mellitus type 1 (T1D) (3 arms), sponsored by The Third Affiliated Hospital of Sun Yat-sen University. Primary endpoint: HbA1c. Planned start Nov 2018; status: not yet recruiting.
02
Drugs
human insulinacarbosemetformin
03
Conditions
diabetes mellitus type 1 (T1D)
Beyond the preview
Go deeper on ChiCTR1800019426.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800019426.